l. 114, No. 12, 2004, pp. 1693-1696. S. E. Cosgrove, G. Skoulas, E. N. Perencevish, M. J. Schwaber, A. W. Karchmer and Y. Carmeli, “Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bactermia: A Meta-Analysis,” Clinical Infectious Diseases, Vol. 36, No. 1, 2003, pp. 53-59. doi:10.1086/345476 M. Whitby, M. L. McLaws and G. Berry, “Risk of Death from Methicillin-Resistant Staphylococcus aureus Bacteremia: A Meta-Analysis,” Medical Journal of Australia, Vol. 175, 2001, pp. 264-267. A. P. Mehta, C. Rodrigues, K. Sheth, S. Jani, A. Hakimiyan and N. Fazalbhoy, “Control of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Centre. A FiveYear Study,” Journal of Medical Microbiology, Vol. 16, 1998, pp. 31-34. S. Anupurba, M. R. Sen, G. Nath, B. M. Sharma, A. K. Gulati and T. M. Mohapatra, “Prevelance of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Referral Hospital in Eastern Uttar Pradesh,” Indian Journal of Medical Microbiology, Vol. 21, No. 1, 2003, pp. 49-51. G. Zanetti, S. J. Goldie and R. Platt, “Clinical Consequencies and Cost of Limiting Use of Vancomycin for Preoperative Prophylaxis: Example of Coronary Artery Bypass Surgery,” Emerging Infectious Diseases, Vol. 7, No. 5, 2001, pp. 820-827. doi:10.3201/eid0705.010508 C. Marshal, S. Wesselingh, M. McDonald and D. Spelman, “Control of Endemic MRSA—What Is the Evidence? A Personal Review,” Journal of Hospital Infection, Vol. 56, No. 4, 2004, pp. 253-268. H. Grundmann, M. Aires-de-Sousa, J. Boyce and E. Tiemersma, “Emergence and Resurgence of MethicillinResistant Staphylococcus aureus as a Public-Health Threat,” Lancet, Vol. 368, No. 9538, 2006, pp. 874-885. doi:10.1016/S0140-6736(06)68853-3 S. I. Kheder, I. Eltayeb, S. A. I. Shaddad and E. Kheder, “Impact of Antibiotic Cycling Policy in Antimicrobial Resistance in, Two Sudanese Surgical Wards Settings: Prospective Longitudinal Interventional Study,” Journal of Pharmaceutical and Biomedical Sciences, Vol. 5, No. 7, 2011, pp. 1-10. S. I. Kheder, “Antibiotic Utilization and Prescribers Adherence Measurements in a Sudanese Hospital Settings after Introducing Antibiotic Policy,” Sudan Medical Monitor, Vol. 6, No. 1, 2011, pp. 39-48. M. Cheesbrough, “District Laboratory Practice in Tropical Countries Part (2),” Cambridge University Press, Cambridge, 1999. National Committee for Clinical Laboratory Standards, “Performance Standards for Antimicrobial Disc Susceptibility Tests, Approved Standard M2-A6,” 6th Edition, NCCLS, Wayne, 1999. J. M. Stelling and T. F. O’breien, “Suroveillance of Antimicrobial Resistance: The WHONET Program,” Clinical Infectious Diseases, Vol. 24, Suppl. 1, 1997, pp. S157- S168. doi:10.1093/clinids/24.Supplement_1.S157 M. A. Alsadig, “Resistance of Pathogenic Bacteria to Antibiotics in Use in Hospitals and Community,” Council of Biological Sciences, New Technologies and Environment Tropical Medicine Programmers’ Khartoum, Sudan Academy of Sciences, SAS, 2007. N. Pal and A. Ayyagari, “Drug Resistance Pattern of Methicillin-Resistant Staphylococcus aureus,” Indian Pediatrics, Vol. 28, 1991, pp. 731-733. M. Borg, E. Scicluna, M. De Kraker, N. Van de Sande, E. Tiemersma, D. Gur, S. Ben Redjeb, O. Rasslan, Z. Elnassar, M. Benbachir, D. Pieridu Bagatzouni, K. Rahal, Z. Daoud, H. Grundmann and J. Monen, “Antibiotic Resistance in the Southeastern Mediterranean. Preliminary Results from AR Medical Project,” European Surveillance, Vol. 11, No. 7, 2006, pp. 164-167. D. J. Diekema, M. A. Pfaller, F. J. Schmitz, J. Smayersky, J. Bell, R. N. Jones, M. Beech and Sentry Partcipant Group, “Survey of Infections Due to Staphylococci Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the Sentry Antimicrobial Surveillance Program, 1997- 1999,” Clinical Infectious Disease, Vol. 32, Suppl. 2, 2001, pp. S114-S132. doi:10.1086/320184 A. C. Fluit, C. L. Wielders, J. Verhoef and F.J. Schmitz, “Epidemiology and Susceptibility of 3051 S. aureus Isolates from 25 University Hospitals Participating in the Europen Sentry Study,” Journal of Clinical Microbiology, Vol. 39, 2001, pp. 3727-3732. doi:10.1128/JCM.39.10.3727-3732.2001 W. Witte, “Antibiotic Resistance in Gram-Positive Bacteria: Epidemiological Aspects,” Journal of Antimicrobial. Chemotherapy, Vol. 44, Suppl. 1, 1999, pp. 1-9. doi:10.1093/jac/44.suppl_1.1 S. I. Kheder, I. Eltayeb and S. A. I. Shaddad, “Evaluation of Hand Hygiene Adherence by Health Care Workers in a Secondary Sudanese Hospital Setting,” Sudan Medical Monitor, Vol. 6, No. 1, 2011, pp. 7-12. H. S. Gold and R. C. Moellering, “Antimicrobial-Drug Resistance,” New England Journal of Medicine, Vol. 335, 1996, pp. 1445-1453. doi:10.1056/NEJM199611073351907 H. Badawi, M. S. Diab and M. Elsaid, “Impact of Antibiotic Policy in a Tertiary Care Research Institute Hospital in Egypt: Three Years Experience,” International Journal of Infection Control, Vol. 3, No. 2, 2007, pp. 1-7. doi:10.3396/03-01-10-07 M. G. Hughes, H. L. Evans, T. W. Chong, R. L. Smith and R. G. Sawyer, “Effect of an Intensive Care Rotating Empiric Antibiotic Schedule on the Development of Hospital-Acquired Infections on the Non-Intensive Care Unit Ward,” Critical Care Medicine, Vol. 32, No. 1, 2004, pp. 53-60. doi:10.1097/01.CCM.0000104463.55423.EF S. I. Kheder, I. Eltayeb, S. A. I. Shaddad and E. Kheder, “Effect of Antibiotic Rotation Protocol on the Development of Hospital Acquired Infections in Hospital Surgical Units in Sudan,” Sudan Medical Monitor, Vol. 5, No. 4, 2010, pp. 165-173.
*Conflict of Interest Statement: We declare that we have no conflict of interest.